e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Factors influencing sputum smear conversion delay in tuberculosis
Soumaya Ben Saad (Bizerte, Tunisia), Islam Mejri, Soumaya Ben Saad, Hahaoua Daghfous, Mouna Ben Khlifa, Fatma Tritar
Source:
International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Session:
Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Session type:
Thematic Poster Session
Number:
2695
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Soumaya Ben Saad (Bizerte, Tunisia), Islam Mejri, Soumaya Ben Saad, Hahaoua Daghfous, Mouna Ben Khlifa, Fatma Tritar. Factors influencing sputum smear conversion delay in tuberculosis. Eur Respir J 2015; 46: Suppl. 59, 2695
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Risk factors and clinical outcomes of delayed smear conversion in smear positive pulmonary tuberculosis
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016
Factors influencing sputum conversion among smear-positive pulmonary tuberculosis patients in Morocco
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013
Factors affecting sputum conversion time in patients with smear positive tuberculosis
Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control
Year: 2007
Factors influencing time to sputum conversion in smear-positive pulmonary tuberculosis
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
A study of patients with pulmonary tuberculosis and confirmed coexistence of nontuberculous mycobacteria during treatment: Does the use of the additional acid-fast bacilli sputum test lead to shorter hospitalization?
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Predictive factors of a delayed culture conversion under tuberculosis treatment
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Factors that affect sputum smear and culture conversion in patients with smear positive pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 428s
Year: 2005
Delayed sputum smear conversion due to cigarette smoking in active pulmonary tuberculosis
Source: International Congress 2016 – Advances in tuberculosis diagnosis and monitoring of treatment
Year: 2016
How long do patients with pulmonary tuberculosis remain smear and culture positive?
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013
Risk factors of time to sputum smear conversion in multi-drugs resistant tuberculosis patients in Iran
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012
Risk factors for late smear and culture conversion in tuberculosis patients
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
Role of fibreoptic bronchoscopy in early diagnosis of sputum smear negative pulmonary tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
Predictive radiological factors of delayed smear conversion
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014
Predictive factors of recurrent pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014
Factors influencing on late bacteriological conversion in pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 420s
Year: 2005
Comparison of yield of acid fast bacilli (AFB) from induced sputum versus gastric lavage for diagnosis of pulmonary tuberculosis in children
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Screening for tuberculosis by sputum culture among risk groups in a TB low- incidence country
Source: International Congress 2014 – Tuberculosis epidemiology: novel features
Year: 2014
Effect of diabetes mellitus on the Time of mycobacterial clearance from sputum during the treatment of multi-drugs resistant tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Experience of using diaskintest in adult patients with tuberculosis and non-tuberculosis respiratory diseases in a regional TB hospital
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
Induced sputum or bronchoscopy in smear negative tuberculosis: A randomized study
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept